Unanswered Questions: AML with IDH Mutations
The optimal induction regimen for intensive chemotherapy-eligible patients with IDH-mutated AML has not been established. In our recently published study, we report outcomes of newly diagnosed IDH-mutated AML treated with intensive chemotherapy plus venetoclax, highlighting efficacy and challenges.